2018
DOI: 10.4172/1745-7580.1000155
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Diagnostic Significance and Cost Effectiveness of ELISA and IFA for the Diagnosis of Autoimmune Disorders

Abstract: Background: The presence of antinuclear antibodies (ANA) is a hallmark of autoimmune diseases. As Clinicopathological classification of autoimmune diseases is difficult without laboratory support, laboratory testing is of helps in diagnosis, treatment, prognosis, and prediction of the pathological changes by disease activity. Although different tests are available for ANA detection enzyme linked immunosorbent assay (ELISA) is the mainstay of diagnosis in most routine laboratories. Indirect immunofluorescence a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
2
1

Year Published

2022
2022
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 11 publications
1
2
1
Order By: Relevance
“…Sharmin et al reported a sensitivity of 86.5% and Bentow et al reported a sensitivity of 81.5%. However, our results were higher than the reported 59% sensitivity of Karumanchi and Oommen [17][18][19].…”
Section: Discussioncontrasting
confidence: 95%
See 2 more Smart Citations
“…Sharmin et al reported a sensitivity of 86.5% and Bentow et al reported a sensitivity of 81.5%. However, our results were higher than the reported 59% sensitivity of Karumanchi and Oommen [17][18][19].…”
Section: Discussioncontrasting
confidence: 95%
“…In contrast, the specificity of the two tests was different, whereas ELISA was more specific than IFA. This observation was also previously reported using different ELISA and IFA kits [18][19][20][21]. These variables were reflected in the positive and negative predictive values of the two procedures, where IFA showed a higher negative predictive value but a lower positive predictive value for SLE compared to ELISA.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Despite being the "gold standard," the Indirect Immunofluorescent Antibody (IFA) test is not frequently utilized. The IFA-ANA test is a useful screening tool because it can identify antimitochondrial and other cytoplasmic antibodies, which ELISA cannot do [36]. The diagnostic usefulness of the recently developed solid-phase screening test Connective Tissue Disease-Screen (CTD-Screen) in identifying ANA in a "real world situation" was assessed.…”
Section: Enzyme Immunosorbent Assaymentioning
confidence: 99%